Escolar Documentos
Profissional Documentos
Cultura Documentos
IDENTITY OF PATIENT
Name : Mr. R Age : 64 y.o Gender : Male Address : Daya MR : 443141 Date of admittance : 9 September 2013
ANAMNESIS
Patient complaints that his both legs was swollen.
The onset was 1 week before admitting in hospital. Cough (+), white serous, appears since 1 week ago Chest pain (-), History of chest pain (+), 10 years ago, doctor advise the patient to do catheterization to put in two stent but the patient refuse to do so. Fever (-), History of fever (-) Nausea (-), Vomit (-)
admitted in hospital Hypertension (-) Diabetes mellitus (-) Cigarette smoking (+) 20 years
Present status: Moderate illness / Well-nourished / Conscious Vital signs: BP : 100/70mmHg HR : 92bpm RR : 36x/min T : 36,5C
Regional status
Head Examination - Eyes : Anemis (-), Icterus (-) - Lip : Cyanosis (-) - Neck : JVP R +2 cmH2O, enlargement of thyroid gland (-) Chest Examination
- Inspection - Palpation - Percussion : Symmetric sinistra et dextra : No mass, no tenderness, VF sinistra = dextra : Sonor sinistra et dextra Lung-liver border in ICS VI right anterior - Auscultation : Breath Sound = Bronchovesicular Additional Sound = Rh , Whz -/-
Cardiac Examination
Inspection : Ictus cordis not visible. Palpation : Ictus cordis not palpable Percussion : Right heart border in right parasternal line, left heart border in left midclavicle line ICS V. Auscultation : Heart Sounds = S I/II regular , murmur (-)
Abdominal - Inspection
: flat, following breath movement, ascites (+) - Auscultation : peristaltic sound (+), normal - Palpation : liver unpalpable spleen unpalpable - Percussion : shifting dullness (+)
Extremities - Oedema pretibial +/+ - Oedema dorsum pedis +/+ - Cyanosis (-), Clubbing finggers (-)
ELECTROCARDIOGRAPHY
Intrepetation of ECG :
Rhythm Heart rate
Regularity
PR interval P wave
Axis
Complex QRS
Duration QRS
T wave Conclusion
: Sinus : 104 bpm : Reguler : 0,08 : Normal : RAD (180) : The height of R wave > S wave at V1 : Pathologic Q wave at V2 V4 : 0,08 : inverted at V1 V3 : Sinus tachicardia, HR 104/mnt, RAD, RVH, OMI anteroseptal, low voltage
Results WBC 7,26 x 10^3/uL PLT 121 x 10^3/uL RBC 5,2 x 10^6/uL HGB 15,9 HCT 24,7
Normal Value 4,00-10,00 150-400 4,00-6,00 13,0-16,0 37,0-48,0 76 52 1,1 26 16 51 6 37 7,9 2,4 110 10-50 <1,3 <38 <41 200 >55 <130 200 3,5-7,0 3,3-5,0 g/dL % mg/dl mg/dl mg/dl U/L U/L mg/dl mg/dl mg/dl mg/dl mg/dl gr/dl
Blood Chemistry
GDP Ur Cr SGOT SGPT Chol Total Chol HDL Chol LDL Uric Acid Albumin
Trigliseride 75
Results CK 60
CKMB Trop-T
Electrolytes Na K Cl
20 0,019
130 4,2 104
D-Dimer 6650
CHEST-XRAY
Conclusion: Cardiomegaly with signs of pulmonary edema Dilatation of aortae Right pleural effusion
USG
Bilateral Pluera Effusion
ECHOCARDIOGRAPHY
LV systolic function decreased EF 38% LVH (-) Dilatation all cardiac space Akinatic anterio septal, hypo kinetic inferio septal, others segment hypo kinetic
WORKING DIAGNOSIS
1. Congestive Heart Failure NYHA III ec CAD 2. Hipoalbumin
MANAGEMENT
Heart Diet IVFD NaCl 0,9% 10 drips/min O2 2 4 liter/min Furosemide 200mg/24h/IV Aspilet 80mg 1-0-0 Farsorbid 10mg 1-1-1 Captopril 6,25mg 1-1-1 Alprazolam 0,5mg 1-0-0 Simvastatin 20mg 0-0-1 Laxadin Syrup 0-0-2C Infus albumin 20% 1 bottle/24 hours
PLANNING
ECG Control
Chest X-Ray
Lab Examination
Heart Failure
Heart no longer able to pump an adequate supply of blood in relation to the venous return and in relation to the metabolic needs of the body tissues at the particular moment The state in which abnormal circulatory congestion occurs as the result of heart failure.
Etiology
Ischemic heart disease
Valve disease Hypertensive heart disease Cardiomyopathy Coronary artery disease
NYHA CLASSIFICATION
Classification NYHA I Description
-No limitation o f physical activity -No symptoms with ordinary exertion -Slight limitation of physical activity - Ordinary activity causes symptoms
-Marked limitation of physical activity -Less than ordinary activity causes symptoms -Asymptomatic at rest
NYHA II
NYHA III
NYHA IV
-Inability to carry out any physical activity without discomfort -Symptoms at rest
Logo The National Heart, Blood, and Company Lung Institute. cited from http://fromyourdoctor.com/.Last updated June 7, 2
Diagnosis
NB : To establish a clinical diagnosis of congestive heart failure by these criteria, at least one major and two minor criteria are required.
TREATMENT
Managing preload Managing contractility
Inotropic agents : Cardiac glycosides B- adrenergic Phosphodiesterase inhibitors Diuretics venodilator
Managing afterload
Ca2+ channel blockers Anti adrenergic Vasodilators
Neurohormonal modulation
the coronary arteries. These arteries supply oxygen-rich blood to the heart muscle.
CAUSES
The major underlying cause is atherosclerosis. It is a slow, progressive disease which begins
in childhood and takes decades to advance. It occurs when plaque builds up in the arteries. The buildup of plaque occurs over many years. Over time, plaque hardens and narrows your coronary arteries. This limits the flow of oxygen-rich blood to your heart muscle.
Endothelial Injury Monocytes becomes macrophages Activate macrophages release free radicals
Oxidize LDL
Toxic to endothelium causing endothelial loss Exposure of subendothelial connective tissue to blood components Platelet adhesion & aggregation fibrin deposition Platelet release various factor Smooth muscle migrates into intima & proliferate Smooth muscle cell, macrophages & matrix accumulate LDL from the plasma
ATHEROMATOUS LESION
PATHOPHYSIOLOGY
RISK FACTOR
Modifiable:
Non-Modifiable :
- Smoking
- Dyslipidemia (Raised LDLC, Low HDL-C, Raised triglycerides) - Raised Blood pressure - Diabetes melitus - Obesity Personal History of CVD Family History of CVD Age Gender
CLASSIFICATION
Coronary Artery Disease Stable angina pectoris Acute Coronary Syndrome
Q wave MI
Non Q wave MI
STEMI
NSTEMI
STEMI
NSTEMI
PATOGENESIS
Unstable Plaque
Occlusive Thrombus
MI Prolonged chest pain Associated symptoms from the autonomic nervous system (nausea, vomiting, diaphoresis)
DIAGNOSIS
Electrocardiogram (ECG)
Echocardiogram
Stress test Cardiac catheterization or angiogram Magnetic resonance angiography (MRA)
TREATMENT
GOAL:
death
NON PHARMACOLOGY:
Lifestyle modification
Pharmacological
Anti Ischemic
Anti Thrombotic
Anti Platelet
Anti Coagulant
THANK YOU